Veradermics Shares Rise After Positive VDPHL01 Phase 3 Trial Data
The company reported positive top-line results from Part A of a placebo-controlled Phase 3 trial of its oral minoxidil formulation in more than 500 males.
The company reported positive top-line results from Part A of a placebo-controlled Phase 3 trial of its oral minoxidil formulation in more than 500 males.